$EXPO
EXPONENT INC

2015 Q3 Form 10-Q Financial Statement

#000114420416116920 Filed on August 05, 2016

View on sec.gov

Income Statement

Concept 2015 Q3
Revenue $79.86M
YoY Change 4.3%
Cost Of Revenue $4.600M
YoY Change 9.52%
Gross Profit $75.30M
YoY Change 4.15%
Gross Profit Margin 94.29%
Selling, General & Admin $49.90M
YoY Change 0.2%
% of Gross Profit 66.27%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.300M
YoY Change 0.0%
% of Gross Profit 1.73%
Operating Expenses $61.16M
YoY Change 1.11%
Operating Profit $18.71M
YoY Change 16.3%
Interest Expense $0.00
YoY Change
% of Operating Profit 0.0%
Other Income/Expense, Net $587.0K
YoY Change -74.63%
Pretax Income $19.29M
YoY Change 4.86%
Income Tax $7.595M
% Of Pretax Income 39.37%
Net Earnings $11.70M
YoY Change 3.84%
Net Earnings / Revenue 14.65%
Basic Earnings Per Share $0.44
Diluted Earnings Per Share $0.43
COMMON SHARES
Basic Shares Outstanding 26.71M shares
Diluted Shares Outstanding 27.37M shares

Balance Sheet

Concept 2015 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $149.9M
YoY Change 3.74%
Cash & Equivalents $131.9M
Short-Term Investments $17.90M
Other Short-Term Assets $25.70M
YoY Change 3.21%
Inventory
Prepaid Expenses
Receivables $93.50M
Other Receivables $0.00
Total Short-Term Assets $269.1M
YoY Change 5.44%
LONG-TERM ASSETS
Property, Plant & Equipment $27.50M
YoY Change -4.62%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $62.80M
YoY Change 5557.66%
Total Long-Term Assets $99.00M
YoY Change 3.23%
TOTAL ASSETS
Total Short-Term Assets $269.1M
Total Long-Term Assets $99.00M
Total Assets $368.1M
YoY Change 4.84%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $9.700M
YoY Change -3.0%
Accrued Expenses $48.90M
YoY Change 2.73%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $64.50M
YoY Change -0.02%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $44.00M
YoY Change 2235.46%
Total Long-Term Liabilities $44.00M
YoY Change 2235.46%
TOTAL LIABILITIES
Total Short-Term Liabilities $64.50M
Total Long-Term Liabilities $44.00M
Total Liabilities $108.5M
YoY Change 3.14%
SHAREHOLDERS EQUITY
Retained Earnings $255.7M
YoY Change 9.53%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $170.2M
YoY Change 16.91%
Treasury Stock Shares 6.931M shares
Shareholders Equity $259.6M
YoY Change
Total Liabilities & Shareholders Equity $368.1M
YoY Change 4.83%

Cashflow Statement

Concept 2015 Q3
OPERATING ACTIVITIES
Net Income $11.70M
YoY Change 3.84%
Depreciation, Depletion And Amortization $1.300M
YoY Change 0.0%
Cash From Operating Activities $13.10M
YoY Change -22.02%
INVESTING ACTIVITIES
Capital Expenditures $1.087M
YoY Change 2.45%
Acquisitions
YoY Change
Other Investing Activities $3.300M
YoY Change
Cash From Investing Activities $2.100M
YoY Change -290.91%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -7.100M
YoY Change -21.11%
NET CHANGE
Cash From Operating Activities 13.10M
Cash From Investing Activities 2.100M
Cash From Financing Activities -7.100M
Net Change In Cash 8.100M
YoY Change 20.9%
FREE CASH FLOW
Cash From Operating Activities $13.10M
Capital Expenditures $1.087M
Free Cash Flow $12.01M
YoY Change -23.67%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
113543000 USD
CY2016Q1 us-gaap Short Term Investments
ShortTermInvestments
45842000 USD
CY2016Q3 us-gaap Short Term Investments
ShortTermInvestments
48518000 USD
CY2016Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
88577000 USD
CY2016Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
92309000 USD
CY2016Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
12616000 USD
CY2016Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
18232000 USD
CY2016Q1 us-gaap Assets Current
AssetsCurrent
272786000 USD
CY2016Q3 us-gaap Assets Current
AssetsCurrent
272602000 USD
CY2016Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
28485000 USD
CY2016Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
29041000 USD
CY2016Q1 us-gaap Goodwill
Goodwill
8607000 USD
CY2016Q3 us-gaap Goodwill
Goodwill
8607000 USD
CY2016Q1 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
39456000 USD
CY2016Q3 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
39031000 USD
CY2016Q1 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
36522000 USD
CY2016Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1651000 USD
CY2016Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1040000 USD
CY2016Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
10580000 USD
CY2016Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
8686000 USD
CY2016Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
62092000 USD
CY2016Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
47516000 USD
CY2016Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
7802000 USD
CY2016Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
125751000 USD
CY2016Q3 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
38034000 USD
CY2016Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
5792000 USD
CY2016Q1 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
40322000 USD
CY2016Q3 us-gaap Liabilities
Liabilities
109305000 USD
CY2016Q1 us-gaap Common Stock Value
CommonStockValue
33000 USD
CY2016Q3 us-gaap Common Stock Value
CommonStockValue
33000 USD
CY2016Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
179816000 USD
CY2016Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
191604000 USD
CY2016Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
269259000 USD
CY2016Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
279196000 USD
CY2016Q3 us-gaap Cost Of Reimbursable Expense
CostOfReimbursableExpense
3961000 USD
CY2015Q3 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
6703000 USD
CY2015Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
165000 USD
CY2016Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
9947000 USD
CY2015Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
131927000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
7284000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
7004000 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
631000 USD
us-gaap Payments Of Dividends
PaymentsOfDividends
8007000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-46000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
2437000 USD
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
4000000 USD
CY2016Q3 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
73334000 USD
CY2015Q3 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
75272000 USD
CY2015Q3 us-gaap Reimbursement Revenue
ReimbursementRevenue
4592000 USD
CY2016Q1 us-gaap Liabilities Current
LiabilitiesCurrent
80474000 USD
CY2016Q3 us-gaap Liabilities Current
LiabilitiesCurrent
61994000 USD
CY2016Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1913000 USD
CY2016Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2116000 USD
CY2016Q3 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
43385000 USD
CY2016Q1 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
1994000 USD
CY2016Q3 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
1810000 USD
CY2016Q1 us-gaap Liabilities
Liabilities
124703000 USD
CY2015Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
19292000 USD
CY2016Q1 expo Entity Wide Sales Revenue Major Customer
EntityWideSalesRevenueMajorCustomer
0.1 pure
CY2015Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
129490000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1714000 USD
CY2016Q1 us-gaap Treasury Stock Value
TreasuryStockValue
184499000 USD
CY2016Q3 us-gaap Treasury Stock Value
TreasuryStockValue
189552000 USD
CY2016Q1 us-gaap Stockholders Equity
StockholdersEquity
262804000 USD
CY2016Q3 us-gaap Stockholders Equity
StockholdersEquity
279050000 USD
CY2016Q3 us-gaap Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
19000 USD
CY2016Q1 us-gaap Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-65000 USD
CY2016Q3 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-2250000 USD
CY2016Q1 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-1740000 USD
CY2016Q3 us-gaap Assets
Assets
388355000 USD
CY2016Q1 us-gaap Assets
Assets
387507000 USD
CY2016Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
388355000 USD
CY2016Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
387507000 USD
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
152284000 USD
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
151413000 USD
us-gaap Reimbursement Revenue
ReimbursementRevenue
8167000 USD
us-gaap Reimbursement Revenue
ReimbursementRevenue
8744000 USD
us-gaap Revenues
Revenues
160451000 USD
us-gaap Revenues
Revenues
160157000 USD
us-gaap Labor And Related Expense
LaborAndRelatedExpense
99057000 USD
us-gaap Labor And Related Expense
LaborAndRelatedExpense
96892000 USD
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
14201000 USD
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
13213000 USD
us-gaap Cost Of Reimbursable Expense
CostOfReimbursableExpense
8167000 USD
us-gaap Cost Of Reimbursable Expense
CostOfReimbursableExpense
8744000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7659000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7575000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
31367000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
33733000 USD
us-gaap Investment Income Net
InvestmentIncomeNet
310000 USD
us-gaap Investment Income Net
InvestmentIncomeNet
68000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2734000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2562000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
34411000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
14333000 USD
us-gaap Net Income Loss
NetIncomeLoss
25803000 USD
us-gaap Net Income Loss
NetIncomeLoss
22030000 USD
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.97
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.83
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.95
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.8
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26572000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26668000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27256000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27386000 shares
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.36
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.3
us-gaap Operating Expenses
OperatingExpenses
129084000 USD
us-gaap Operating Expenses
OperatingExpenses
126424000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3044000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2630000 USD
CY2016Q3 us-gaap Reimbursement Revenue
ReimbursementRevenue
3961000 USD
CY2016Q3 us-gaap Revenues
Revenues
77295000 USD
CY2015Q3 us-gaap Revenues
Revenues
79864000 USD
CY2016Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
47040000 USD
CY2015Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
45777000 USD
CY2015Q3 us-gaap Cost Of Reimbursable Expense
CostOfReimbursableExpense
4592000 USD
CY2016Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
14931000 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-9712000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
36363000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8608000 USD
CY2016Q3 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
7218000 USD
CY2015Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4087000 USD
CY2015Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
18705000 USD
CY2016Q3 us-gaap Investment Income Net
InvestmentIncomeNet
171000 USD
CY2015Q3 us-gaap Investment Income Net
InvestmentIncomeNet
34000 USD
CY2016Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1575000 USD
CY2015Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
553000 USD
CY2016Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
16677000 USD
CY2016Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6224000 USD
CY2015Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7595000 USD
CY2016Q3 us-gaap Net Income Loss
NetIncomeLoss
10453000 USD
CY2015Q3 us-gaap Net Income Loss
NetIncomeLoss
11697000 USD
CY2016Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.39
CY2015Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.44
CY2016Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.38
CY2015Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.43
CY2016Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26631000 shares
CY2015Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26714000 shares
CY2016Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27264000 shares
CY2015Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27368000 shares
CY2016Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.18
CY2015Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.15
CY2016Q3 us-gaap Operating Expenses
OperatingExpenses
62364000 USD
CY2015Q3 us-gaap Operating Expenses
OperatingExpenses
61159000 USD
CY2016Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1746000 USD
CY2015Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
587000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-510000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-336000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
84000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-17000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
25377000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
21677000 USD
CY2016Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-505000 USD
CY2016Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-1000 USD
CY2015Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-10000 USD
CY2015Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
11852000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
2927000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
2705000 USD
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-14000 USD
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-395000 USD
us-gaap Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
-184000 USD
us-gaap Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
-7000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1131000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
509000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
7929000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
7902000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
424000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1071000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
0 USD
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
4486000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4863000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
7684000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
5198000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1195000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1716000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
5117000 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-9446000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-2010000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-2339000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
14545000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
14820000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3382000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
4841000 USD
us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
21450000 USD
us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
10555000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-5932000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
0 USD
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
4486000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
7613000 USD
CY2015Q4 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
3870000 USD
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2016Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
3867000 USD
CY2016 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
15482000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
4458000 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
1229000 USD
us-gaap Payments Of Dividends
PaymentsOfDividends
9515000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-20357000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-17178000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-464000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-12208000 USD
CY2016Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1524000 USD
CY2015Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1324000 USD
CY2016Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1901000 USD
CY2015Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1087000 USD
CY2016Q3 expo Entity Wide Sales Revenue Major Customer
EntityWideSalesRevenueMajorCustomer
0.1 pure
CY2016Q3 expo Entity Wide Account Receivable Major Customer Percentage
EntityWideAccountReceivableMajorCustomerPercentage
0.1 pure
us-gaap Income Taxes Paid
IncomeTaxesPaid
11808000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
10235000 USD
expo Vested Restricted Stock Awards Issued To Settle Accrued Bonuses
VestedRestrictedStockAwardsIssuedToSettleAccruedBonuses
6334000 USD
expo Vested Restricted Stock Awards Issued To Settle Accrued Bonuses
VestedRestrictedStockAwardsIssuedToSettleAccruedBonuses
6169000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
422000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
226000 USD
CY2014Q2 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
35000000 USD
CY2015Q4 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
35000000 USD
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
90505 shares
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
162833 shares
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
7004000 USD
CY2016Q3 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
42306000 USD
us-gaap Treasury Stock Reissued At Lower Than Repurchase Price
TreasuryStockReissuedAtLowerThanRepurchasePrice
5791000 USD
us-gaap Treasury Stock Reissued At Lower Than Repurchase Price
TreasuryStockReissuedAtLowerThanRepurchasePrice
4943000 USD
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
4458000 USD
CY2015Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.15
CY2015Q3 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.15
CY2015Q4 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.15
CY2016Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.15
CY2015Q2 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
3858000 USD
CY2015Q3 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
3887000 USD
CY2016 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.6
CY2016Q3 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.18
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
9303000 USD
CY2016Q3 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
32211000 USD
CY2016Q3 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
124756000 USD
CY2016Q3 expo Deferred Compensation Plan Liabilities Fair Value Disclosure
DeferredCompensationPlanLiabilitiesFairValueDisclosure
49377000 USD
CY2016Q3 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
49377000 USD
CY2016Q1 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
10530000 USD
CY2016Q1 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
99312000 USD
CY2016Q1 expo Deferred Compensation Plan Liabilities Fair Value Disclosure
DeferredCompensationPlanLiabilitiesFairValueDisclosure
46740000 USD
CY2016Q1 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
46740000 USD
CY2016Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
162030000 USD
CY2016Q3 expo Available For Sale Securities Gross Unrealized Gain Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments
31000 USD
CY2016Q3 expo Available For Sale Securities Gross Unrealized Loss Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments
0 USD
CY2016Q3 expo Cash Cash Equivalents And Short Term Investments Fair Value Disclosure
CashCashEquivalentsAndShortTermInvestmentsFairValueDisclosure
162061000 USD
CY2016Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
171699000 USD
CY2016Q1 expo Available For Sale Securities Gross Unrealized Gain Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments
1000 USD
CY2016Q1 expo Available For Sale Securities Gross Unrealized Loss Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments
107000 USD
CY2016Q1 expo Cash Cash Equivalents And Short Term Investments Fair Value Disclosure
CashCashEquivalentsAndShortTermInvestmentsFairValueDisclosure
171593000 USD
CY2016Q3 expo Available For Sale Securities Short Term Investments Amortized Cost Due In Year One
AvailableForSaleSecuritiesShortTermInvestmentsAmortizedCostDueInYearOne
8487000 USD
CY2016Q3 expo Available For Sale Securities Short Term Investments Amortized Cost Due In Year Two
AvailableForSaleSecuritiesShortTermInvestmentsAmortizedCostDueInYearTwo
40000000 USD
CY2016Q3 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
48487000 USD
CY2016Q3 expo Available For Sale Securities Short Term Investments Estimated Fair Value Due In Year One
AvailableForSaleSecuritiesShortTermInvestmentsEstimatedFairValueDueInYearOne
8497000 USD
CY2016Q3 expo Available For Sale Securities Short Term Investments Estimated Fair Value Due In Year Two
AvailableForSaleSecuritiesShortTermInvestmentsEstimatedFairValueDueInYearTwo
40021000 USD
dei Document Type
DocumentType
10-Q
dei Amendment Flag
AmendmentFlag
false
dei Document Period End Date
DocumentPeriodEndDate
2016-07-01
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2016
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Registrant Name
EntityRegistrantName
EXPONENT INC
dei Entity Central Index Key
EntityCentralIndexKey
0000851520
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-30
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2016Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
25984414 shares
CY2016Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2231000 USD
CY2016Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1805000 USD
CY2016Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
3619000 USD
CY2016Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2792000 USD
CY2016Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2016Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2016Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000 shares
CY2016Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000 shares
CY2016Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
32853000 shares
CY2016Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
32853000 shares
CY2016Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
6868000 shares
CY2016Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
7133000 shares
dei Trading Symbol
TradingSymbol
EXPO
CY2016Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.18
us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.36
CY2016Q2 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
4628000 USD
CY2016Q3 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
4675000 USD
CY2016Q3 expo Change In Market Value Of Deferred Compensation Trust Assets
ChangeInMarketValueOfDeferredCompensationTrustAssets
938000 USD
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 pure
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
0 USD
us-gaap Goodwill Other Increase Decrease
GoodwillOtherIncreaseDecrease
0 USD
us-gaap Goodwill Period Increase Decrease
GoodwillPeriodIncreaseDecrease
0 USD
CY2015Q3 expo Change In Market Value Of Deferred Compensation Trust Assets
ChangeInMarketValueOfDeferredCompensationTrustAssets
-72000 USD
CY2015Q3 expo Entity Wide Account Receivable Major Customer Percentage
EntityWideAccountReceivableMajorCustomerPercentage
0.1 pure
expo Share Based Compensation Arrangements By Share Based Payment Award Options Expiration Term
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationTerm
P10Y
us-gaap Use Of Estimates
UseOfEstimates
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: bold 10pt Times New Roman, Times, Serif" align="justify">Use of Estimates. <font style="FONT-WEIGHT: normal">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period. Significant items subject to such estimates and assumptions include accounting for revenue recognition and estimating the allowance for contract losses and doubtful accounts. Actual results could differ from those estimates.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>

Files In Submission

Name View Source Status
0001144204-16-116920-index-headers.html Edgar Link pending
0001144204-16-116920-index.html Edgar Link pending
0001144204-16-116920.txt Edgar Link pending
0001144204-16-116920-xbrl.zip Edgar Link pending
expo-20160701.xml Edgar Link completed
expo-20160701.xsd Edgar Link pending
expo-20160701_cal.xml Edgar Link unprocessable
expo-20160701_def.xml Edgar Link unprocessable
expo-20160701_lab.xml Edgar Link unprocessable
expo-20160701_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v444851_10q.htm Edgar Link pending
v444851_ex31-1.htm Edgar Link pending
v444851_ex31-2.htm Edgar Link pending
v444851_ex32-1.htm Edgar Link pending
v444851_ex32-2.htm Edgar Link pending